Pharma outsourcing trends 2025: partnership, precision and resilience

Published: 28-Aug-2025

The Bachem team shares its insights on the evolving relationship between pharma companies and CDMOs

You need to be a subscriber to read this article.
Click here to find out more.

Outsourcing plays a critical role in modern drug development and manufacturing: one that has gained increasing importance in recent years.

The continued rise in demand for complex modalities, such as peptides and oligonucleotides, and increased pressures on time-to-market, have amplified the need for external partnerships and collaboration to ensure the supply of crucial medications to patients. 

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.

You may also like